Literature DB >> 9232530

Prediction of distribution coefficient from structure. 1. Estimation method.

F Csizmadia1, A Tsantili-Kakoulidou, I Panderi, F Darvas.   

Abstract

A method has been developed for the estimation of the distribution coefficient (D), which considers the microspecies of a compound. D is calculated from the microscopic dissociation constants (microconstants), the partition coefficients of the microspecies, and the counterion concentration. A general equation for the calculation of D at a given pH is presented. The microconstants are calculated from the structure using Hammett and Taft equations. The partition coefficients of the ionic microspecies are predicted by empirical equations using the dissociation constants and the partition coefficient of the uncharged species, which are estimated from the structure by a Linear Free Energy Relationship method. The algorithm is implemented in a program module called PrologD.

Mesh:

Substances:

Year:  1997        PMID: 9232530     DOI: 10.1021/js960177k

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  22 in total

1.  Prediction of distribution coefficients from structure. Comparison of calculated and experimental data for various drugs.

Authors:  A Tsantili-Kakoulidou; I Panderi; S Piperaki; F Csizmadia; F Darvas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jul-Sep       Impact factor: 2.441

2.  Exploiting Enzymatic Dynamic Reductive Kinetic Resolution (DYRKR) in Stereocontrolled Synthesis.

Authors:  Gregory A Applegate; David B Berkowitz
Journal:  Adv Synth Catal       Date:  2015-05-12       Impact factor: 5.837

3.  Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay.

Authors:  Luca A Fenu; Ard Teisman; Stefan S De Buck; Vikash K Sinha; Ron A H J Gilissen; Marjoleen J M A Nijsen; Claire E Mackie; Wendy E Sanderson
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

4.  A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence.

Authors:  Jessica L Childs-Disney; Tuan Tran; Balayeshwanth R Vummidi; Sai Pradeep Velagapudi; Hafeez S Haniff; Yasumasa Matsumoto; Gogce Crynen; Mark R Southern; Avik Biswas; Zi-Fu Wang; Timothy L Tellinghuisen; Matthew D Disney
Journal:  Chem       Date:  2018-09-13       Impact factor: 22.804

5.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

Authors:  Sichao Wang; Youyong Li; Junmei Wang; Lei Chen; Liling Zhang; Huidong Yu; Tingjun Hou
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

6.  3-Nitrotyrosine as a spectroscopic probe for investigating protein protein interactions.

Authors:  Vincenzo De Filippis; Roberta Frasson; Angelo Fontana
Journal:  Protein Sci       Date:  2006-05       Impact factor: 6.725

7.  Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.

Authors:  Andrii Monastyrskyi; Napon Nilchan; Victor Quereda; Yoshihiko Noguchi; Claudia Ruiz; Wayne Grant; Michael Cameron; Derek Duckett; William Roush
Journal:  Bioorg Med Chem       Date:  2017-12-15       Impact factor: 3.641

8.  Molecular modeling and QSAR studies of a set of indole and benzimidazole derivatives as H₄ receptor antagonists.

Authors:  João Paulo S Fernandes; Kerly Fernanda M Pasqualoto; Elizabeth I Ferreira; Carlos A Brandt
Journal:  J Mol Model       Date:  2010-07-06       Impact factor: 1.810

9.  SAMPL4 & DOCK3.7: lessons for automated docking procedures.

Authors:  Ryan G Coleman; Teague Sterling; Dahlia R Weiss
Journal:  J Comput Aided Mol Des       Date:  2014-02-11       Impact factor: 3.686

10.  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

Authors:  David F V Lewis
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.